Monoclonal antibodies against SU-DHL-1 cells stain the neoplastic cells in true histiocytic lymphoma, malignant histiocytosis, and Hodgkin's disease.
about
Lack of effect of colony-stimulating factors, interleukins, interferons, and tumor necrosis factor on the growth and differentiation of cultured Reed-Sternberg cells. Comparison with effects of phorbol ester and retinoic acidLymphocyte functional antigens stabilize agglutination between Reed-Sternberg cells and T cells, but are not responsible for homotypic binding of Hodgkin's Reed-Sternberg cellsCultured Reed-Sternberg cells HDLM-1 and KM-H2 can be induced to become histiocytelike cells. H-RS cells are not derived from lymphocytes.Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells?Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2Heterogeneity of interleukin 1 production in cultured Reed-Sternberg cell lines HDLM-1, HDLM-1d, and KM-H2.Expression of prostaglandin H synthase (cyclooxygenase) in Hodgkin's mononuclear and Reed-Sternberg cells. Functional resemblance between H-RS cells and histiocytes or interdigitating reticulum cells.Correlation of c-fos/c-jun expression with histiocytic differentiation in Hodgkin's Reed-Sternberg cells. Examination in HDLM-1 subclones with spontaneous differentiation.Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's diseaseExpression of interleukin-1 in Reed-Sternberg cells and neoplastic cells from true histiocytic malignancies.The H-RS-like cells in infectious mononucleosis are transformed interdigitating reticulum cells.Extracellular matrix does not induce the proliferation, but promotes the differentiation, of Hodgkin's cell line HDLM-1.Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).
P2860
Q35811315-CCE4B80D-9DCE-43B7-A462-B20C3FD2CF1FQ35811548-225E65ED-7E3B-4BE9-A846-11E82054B643Q35811817-0560904F-DB57-48FA-A13D-D753A4DE35B4Q35816024-EC745162-80EC-48A3-A1FD-4919EC8A8FACQ35817197-4F1C2946-CA49-43D4-8726-17F5107D74FDQ35817633-EEEB0AC6-6960-45E7-86A7-0BB7C81EA95CQ35818633-F3394999-2026-422F-BF55-674D542087D2Q35830942-94B79836-4393-40CE-8AE4-9571F59B2D23Q35831873-0C8AE9CB-2217-4CCA-8625-B98B581E5BC0Q41452223-3AB108F5-34DC-460C-8282-E57912D84419Q41769470-346A21D9-8956-4A50-A648-21C1CC51E4ADQ42045311-2DC1E9C8-2187-449E-AC3A-A5E08FF11F26Q42065454-2A26E242-5BE3-44F3-BDD0-3E29F0FC91BE
P2860
Monoclonal antibodies against SU-DHL-1 cells stain the neoplastic cells in true histiocytic lymphoma, malignant histiocytosis, and Hodgkin's disease.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh-hant
name
Monoclonal antibodies against ...... ytosis, and Hodgkin's disease.
@en
Monoclonal antibodies against ...... ytosis, and Hodgkin's disease.
@nl
type
label
Monoclonal antibodies against ...... ytosis, and Hodgkin's disease.
@en
Monoclonal antibodies against ...... ytosis, and Hodgkin's disease.
@nl
prefLabel
Monoclonal antibodies against ...... ytosis, and Hodgkin's disease.
@en
Monoclonal antibodies against ...... ytosis, and Hodgkin's disease.
@nl
P2093
P1433
P1476
Monoclonal antibodies against ...... ytosis, and Hodgkin's disease.
@en
P2093
P304
P407
P577
1986-07-01T00:00:00Z